English
简体中文
Total: £ 56.28
Published Date: 2026-03-31 | Pages: 102 | Tables: 109 | Medical Devices & Consumables
The global Sexually Transmitted Diseases (STD) Diagnostics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Sexually Transmitted Diseases (STD) Diagnostics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Sexually Transmitted Diseases (STD) Diagnostics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Sexually Transmitted Diseases (STD) Diagnostics in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Sexually Transmitted Diseases (STD) Diagnostics include F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Hologic Inc., Creative Diagnostics, Abbott Laboratories, Quest Diagnostics, BD, QIAGEN, Cepheid, bioMerieux Inc., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Sexually Transmitted Diseases (STD) Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sexually Transmitted Diseases (STD) Diagnostics. The Sexually Transmitted Diseases (STD) Diagnostics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Sexually Transmitted Diseases (STD) Diagnostics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Sexually Transmitted Diseases (STD) Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
F.Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Hologic Inc.
Creative Diagnostics
Abbott Laboratories
Quest Diagnostics
BD
QIAGEN
Cepheid
bioMerieux Inc.
Segment by Type
Molecular Test
Serologic Test
Point of Care Test
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Sexually Transmitted Diseases (STD) Diagnostics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Molecular Test
1.2.3 Serologic Test
1.2.4 Point of Care Test
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Perspective (2021–2032)
2.2 Global Sexually Transmitted Diseases (STD) Diagnostics Growth Trends by Region
2.2.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Sexually Transmitted Diseases (STD) Diagnostics Historic Market Size by Region (2021–2026)
2.2.3 Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Region (2027–2032)
2.3 Sexually Transmitted Diseases (STD) Diagnostics Market Dynamics
2.3.1 Sexually Transmitted Diseases (STD) Diagnostics Industry Trends
2.3.2 Sexually Transmitted Diseases (STD) Diagnostics Market Drivers
2.3.3 Sexually Transmitted Diseases (STD) Diagnostics Market Challenges
2.3.4 Sexually Transmitted Diseases (STD) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Diseases (STD) Diagnostics Players by Revenue
3.1.1 Global Top Sexually Transmitted Diseases (STD) Diagnostics Players by Revenue (2021–2026)
3.1.2 Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Players (2021–2026)
3.2 Global Top Sexually Transmitted Diseases (STD) Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Sexually Transmitted Diseases (STD) Diagnostics Revenue
3.4 Global Sexually Transmitted Diseases (STD) Diagnostics Market Concentration Ratio
3.4.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Diagnostics Revenue in 2025
3.5 Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics Head Offices and Areas Served
3.6 Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Products and Applications
3.7 Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Sexually Transmitted Diseases (STD) Diagnostics Breakdown Data by Type
4.1 Global Sexually Transmitted Diseases (STD) Diagnostics Historic Market Size by Type (2021–2026)
4.2 Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Type (2027–2032)
5 Sexually Transmitted Diseases (STD) Diagnostics Breakdown Data by Application
5.1 Global Sexually Transmitted Diseases (STD) Diagnostics Historic Market Size by Application (2021–2026)
5.2 Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size (2021–2032)
6.2 North America Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2021–2026)
6.4 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size (2021–2032)
7.2 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2021–2026)
7.4 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size (2021–2032)
8.2 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2021–2026)
8.4 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size (2021–2032)
9.2 Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2021–2026)
9.4 Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size (2021–2032)
10.2 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2021–2026)
10.4 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F.Hoffmann-La Roche Ltd
11.1.1 F.Hoffmann-La Roche Ltd Company Details
11.1.2 F.Hoffmann-La Roche Ltd Business Overview
11.1.3 F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.1.4 F.Hoffmann-La Roche Ltd Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
11.1.5 F.Hoffmann-La Roche Ltd Recent Development
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Details
11.2.2 Thermo Fisher Scientific Inc. Business Overview
11.2.3 Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
11.2.5 Thermo Fisher Scientific Inc. Recent Development
11.3 Hologic Inc.
11.3.1 Hologic Inc. Company Details
11.3.2 Hologic Inc. Business Overview
11.3.3 Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.3.4 Hologic Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
11.3.5 Hologic Inc. Recent Development
11.4 Creative Diagnostics
11.4.1 Creative Diagnostics Company Details
11.4.2 Creative Diagnostics Business Overview
11.4.3 Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.4.4 Creative Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
11.4.5 Creative Diagnostics Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.5.4 Abbott Laboratories Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
11.5.5 Abbott Laboratories Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Details
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.6.4 Quest Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
11.6.5 Quest Diagnostics Recent Development
11.7 BD
11.7.1 BD Company Details
11.7.2 BD Business Overview
11.7.3 BD Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.7.4 BD Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
11.7.5 BD Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Details
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.8.4 QIAGEN Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
11.8.5 QIAGEN Recent Development
11.9 Cepheid
11.9.1 Cepheid Company Details
11.9.2 Cepheid Business Overview
11.9.3 Cepheid Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.9.4 Cepheid Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
11.9.5 Cepheid Recent Development
11.10 bioMerieux Inc.
11.10.1 bioMerieux Inc. Company Details
11.10.2 bioMerieux Inc. Business Overview
11.10.3 bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.10.4 bioMerieux Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
11.10.5 bioMerieux Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Molecular Test
Table 3. Key Players of Serologic Test
Table 4. Key Players of Point of Care Test
Table 5. Key Players of Others
Table 6. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 9. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Region (2021–2026)
Table 10. Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Region (2027–2032)
Table 12. Sexually Transmitted Diseases (STD) Diagnostics Market Trends
Table 13. Sexually Transmitted Diseases (STD) Diagnostics Market Drivers
Table 14. Sexually Transmitted Diseases (STD) Diagnostics Market Challenges
Table 15. Sexually Transmitted Diseases (STD) Diagnostics Market Restraints
Table 16. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue by Players (US$ Million), 2021–2026
Table 17. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Players (2021–2026)
Table 18. Global Top Sexually Transmitted Diseases (STD) Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Sexually Transmitted Diseases (STD) Diagnostics Revenue, 2025
Table 19. Ranking of Global Top Sexually Transmitted Diseases (STD) Diagnostics Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Sexually Transmitted Diseases (STD) Diagnostics Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Products and Applications
Table 23. Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (US$ Million), 2021–2026
Table 26. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Type (2021–2026)
Table 27. Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Type (2027–2032)
Table 29. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (US$ Million), 2021–2026
Table 30. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Application (2021–2026)
Table 31. Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Application (2027–2032)
Table 33. North America Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 35. North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 48. F.Hoffmann-La Roche Ltd Company Details
Table 49. F.Hoffmann-La Roche Ltd Business Overview
Table 50. F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Product
Table 51. F.Hoffmann-La Roche Ltd Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026
Table 52. F.Hoffmann-La Roche Ltd Recent Development
Table 53. Thermo Fisher Scientific Inc. Company Details
Table 54. Thermo Fisher Scientific Inc. Business Overview
Table 55. Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Product
Table 56. Thermo Fisher Scientific Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026
Table 57. Thermo Fisher Scientific Inc. Recent Development
Table 58. Hologic Inc. Company Details
Table 59. Hologic Inc. Business Overview
Table 60. Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Product
Table 61. Hologic Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026
Table 62. Hologic Inc. Recent Development
Table 63. Creative Diagnostics Company Details
Table 64. Creative Diagnostics Business Overview
Table 65. Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product
Table 66. Creative Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026
Table 67. Creative Diagnostics Recent Development
Table 68. Abbott Laboratories Company Details
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Product
Table 71. Abbott Laboratories Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026
Table 72. Abbott Laboratories Recent Development
Table 73. Quest Diagnostics Company Details
Table 74. Quest Diagnostics Business Overview
Table 75. Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product
Table 76. Quest Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026
Table 77. Quest Diagnostics Recent Development
Table 78. BD Company Details
Table 79. BD Business Overview
Table 80. BD Sexually Transmitted Diseases (STD) Diagnostics Product
Table 81. BD Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026
Table 82. BD Recent Development
Table 83. QIAGEN Company Details
Table 84. QIAGEN Business Overview
Table 85. QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Product
Table 86. QIAGEN Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026
Table 87. QIAGEN Recent Development
Table 88. Cepheid Company Details
Table 89. Cepheid Business Overview
Table 90. Cepheid Sexually Transmitted Diseases (STD) Diagnostics Product
Table 91. Cepheid Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026
Table 92. Cepheid Recent Development
Table 93. bioMerieux Inc. Company Details
Table 94. bioMerieux Inc. Business Overview
Table 95. bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Product
Table 96. bioMerieux Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026
Table 97. bioMerieux Inc. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Sexually Transmitted Diseases (STD) Diagnostics Picture
Figure 2. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Type: 2025 vs 2032
Figure 4. Molecular Test Features
Figure 5. Serologic Test Features
Figure 6. Point of Care Test Features
Figure 7. Others Features
Figure 8. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Sexually Transmitted Diseases (STD) Diagnostics Report Years Considered
Figure 14. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Region: 2025 vs 2032
Figure 17. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Players in 2025
Figure 18. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Diagnostics Revenue in 2025
Figure 20. North America Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Sexually Transmitted Diseases (STD) Diagnostics Market Share by Country (2021–2032)
Figure 22. United States Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Share by Country (2021–2032)
Figure 26. Germany Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Share by Region (2021–2032)
Figure 34. China Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Share by Country (2021–2032)
Figure 42. Mexico Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Share by Country (2021–2032)
Figure 46. Israel Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. F.Hoffmann-La Roche Ltd Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
Figure 50. Thermo Fisher Scientific Inc. Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
Figure 51. Hologic Inc. Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
Figure 52. Creative Diagnostics Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
Figure 53. Abbott Laboratories Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
Figure 54. Quest Diagnostics Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
Figure 55. BD Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
Figure 56. QIAGEN Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
Figure 57. Cepheid Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
Figure 58. bioMerieux Inc. Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
